FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Could HHS Mea Culpa Lead to FDA Rehires?

[ Price : $8.95]

HHS secretary Robert F. Kennedy Jr. admits that many mistakes were made in cuts across HHS health agencies, including FDA, and tha...

House Committee Hearing on Reducing FDA Inefficiencies

[ Price : $8.95]

The U.S. House Committee on Oversight and Government Reform announces a 4/9 hearing on reducing inefficiencies and the bureaucracy...

Marks: RFK Jr. Wants FDA to Support Stem-cell Treatments

[ Price : $8.95]

CBER director Peter Marks speaks out about the pressure he faced before given the option to resign or be fired for questioning HHS...

Draeger Recalls Flex 220 Breathing Circuit

[ Price : $8.95]

Draeger recalls its Flex 220 ID breathing circuit due to the risk of cracks forming in the breathing circuit hose.

Breakthrough Status for Uveal Melanoma Therapy

[ Price : $8.95]

FDA grants Ideaya Biosciences a breakthrough therapy designation for darovasertib for neoadjuvant use in adult patients with prima...

CRL for Aldeyras Reproxalap for Dry Eye

[ Price : $8.95]

FDA issues a complete response letter to Aldeyras NDA for reproxalap to treat dry eye disease, citing a lack of efficacy in the su...

Reorganization Will Block Information Flow

[ Price : $8.95]

FDA Webview Contributing Editor John Hope says the dismissal of agency communications staff will hurt information flow to the publ...

Makary Will Face Political Interference Soon: Gottlieb

[ Price : $8.95]

Former FDA commissioner Scott Gottlieb predicts just-confirmed FDA commissioner Marty Makary will soon face political interference...

BeiGene Drops Ociperlimab Development in Lung Cancer

[ Price : $8.95]

BeiGene scraps the development of BGB-A1217 (ociperlimab), an anti-TIGIT antibody, as a potential treatment for lung cancer.

Accelerated Approval Faces Scrutiny After Cancer Drug Review

[ Price : $8.95]

FDAs accelerated approval program faces renewed scrutiny after a recent JAMA study highlighted concerns about cancer drugs that re...